BioNovelus Product CR-10 Set to Save Coffee Industry!
SCOTTSDALE, AZ -- May 5, 2016 -- InvestorsHub NewsWire --
BioNovelus, Inc. (PINKSHEETS:
ONOV) is pleased to announce the triumph of CR-10, their
environmentally friendly fungicide product. Test results in five
coffee plantations have proven that biodegradable CR-10 is a coffee
rust killer! Coffee rust or "roya" (Hemileia vastatrix) is a
devastating fungus that has already cost $2.5B to the coffee
industry and 500,000 jobs in Central America since 2012. (Sources:
ICAFE 02/2016 and Forbes 08/2014).
Since 2014, big name brands of coffee such as Starbucks, Keurig
Green Mountain, Folgers maker J.M. Smucker, San Francisco Bay
Coffee, along with USAID and several organizations have thrown over
$25M at the rust issue, trying to resolve it primarily by creating
genetically modified (GMO) rust-resistant trees, which does not
address the rust itself. Two years and a several million dollars
later, coffee rust is still very present in Central America.
CR-10 saves the day! Victor Hugo Carranza Salazar, CEO of
CoopeAgri R.L., a $106M revenue cooperative in Costa Rica, active
partner of Arizona based BioNovelus in this Pilot Test, explains:
"CR-10 is a new real opportunity that gives hopes." He also admits
that coffee rust is a plague and in 2015 his cooperative of 14,000
members lost $11M to the disease.
To quote Business Insider: "After crude oil, coffee is the most
sought after commodity. Coffee is worth over $100B annually
worldwide." "BioNovelus product, CR-10, is the most viable and
proven solution to eradicate coffee rust, says Jean Ekobo,
President of BioNovelus. CR-10 has already been approved by Costa
Rican Customs, and we are in advanced negotiations with
distributors for CR-10 in Costa Rica, and other countries in
Central America, and Mexico."
Rather than genetically modified trees, or continual use of
environmentally dangerous chemicals, BioNovelus offers to eliminate
the rust devastation with their biodegradable, non toxic CR-10.
CR-10 is the perfect solution for our planet.
About BioNovelus Inc.
BioNovelus, Inc. (PINKSHEETS:
ONOV) is a biotech company that honors the environment with an
innovative, cost effective, and disruptive technology-based
solution to the problems of safety and cleanliness regarding food
production and water supply.
Additional Information
For additional information: http://bionovelus.com/results/
Please contact: Nathalie Ekobo,
Marketing & Communications Director
BioNovelus, Inc.:
Skype: bionovelus.inc
+1 602-888-3424
NEkobo@BioNovelus.com
Forward-Looking Statements
This news release includes forward-looking statements covered by
the Private Securities Litigation Reform Act of 1995. Because such
statements deal with future events, they are subject to various
risks and uncertainties and actual results for fiscal year 2015 and
beyond could differ materially from the Company's current
expectations. Forward-looking statements are identified by words
such as "anticipates," "projects," "expects," "plans," "intends,"
"believes," "estimates," "targets," and other similar expressions
that indicate trends and future events.
Factors that could cause the Company's results to differ
materially from those expressed in forward-looking statements
include, without limitation, variation in demand and acceptance of
the Company's products and services, the frequency, magnitude and
timing of paper and other raw-material-price changes, general
business and economic conditions beyond the Company's control,
timing of the completion and integration of acquisitions, the
consequences of competitive factors in the marketplace including
the ability to attract and retain customers, results of continuous
improvement and other cost-containment strategies, and the
Company's success in attracting and retaining key personnel. The
Company undertakes no obligation to revise or update
forward-looking statements as a result of new information, since
these statements may no longer be accurate or timely.
Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933, and are subject to Rule 3B-6 under the
Securities Exchange Act of 1934, and are subject to the safe harbor
created by those rules. All statements, other than statements of
fact, included in this press release, including, without
limitation, statements regarding potential future plans and
objectives of the company, are forward-looking statements that
involve risks and uncertainties. There can be no assurance that
such statements will prove to be accurate and other results and
further events could differ materially from those anticipated in
such statements. Future events and actual results could differ
materially from those set forth in, contemplated by, or underlying
the forward-looking statements.
SOURCE: BioNovelus Inc.